Skip to content

News & Events

Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

International Thoracic Oncology Experts – ESMO Panel Discussion
ATOMIC Director Ross Camidge MD, PhD, draws out novel opinions across the field of thoracic oncology from a panel of international experts discussing their favorite ESMO abstracts from 2022.
Industry News: Brain MRI surveillance needed for TKl-treated ALK or ROS7-positive NSCLC
Retrospective data showed how common central nervous system metastases are among patients with non-small cell lung cancer and ALK or ROS1 alterations who have been treated with tyrosine kinase inhibitors.
PharmaVoice Interview with Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)
Watch the PharmaVoice One on One video interview below to learn more about the latest in Thoracic Oncology research from Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium and Director of Thoracic Oncology at the University of Colorado.
CRITERIUM, Inc. CRO’s ATOMIC PI Leora Horn, MD, Highlighted in ASCOPOST Article
ATOMIC Investigator, Leora Horn, MD, Director of Clinical Research at Vanderbilt University's Ingram Cancer Center, was highlighted in a recent biographical article by the ASCOPOST about her "Journey to a Career in Oncology..." that has taken her from Johannesburg, South Africa to Toronto, Canada to Kentucky.
CRITERIUM, Inc. CRO’s ATOMIC PI’s Co-Author on Medicine Matters
Two ATOMIC Investigators, Natasha B. Leighl, MD, MMSc, FRCPC, and Stephen V. Liu, MD, co-authored an article published online in Medicine Matters outlining how "immunotherapy has forever changed the management of non-small cell lung cancer (NSCLC)."